4//SEC Filing
CDK ASSOCIATES, L.L.C. 4
Accession 0000919574-18-008212
CIK 0001634432other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:39 PM ET
Size
10.7 KB
Accession
0000919574-18-008212
Insider Transaction Report
Form 4
CAXTON CORP
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-12-26$4.00/sh+31,197$124,698→ 6,563,105 total - Purchase
Ordinary Shares, $0.01 par value
2018-12-27$3.98/sh+18,200$72,434→ 6,581,305 total
CDK ASSOCIATES, L.L.C.
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-12-26$4.00/sh+31,197$124,698→ 6,563,105 total - Purchase
Ordinary Shares, $0.01 par value
2018-12-27$3.98/sh+18,200$72,434→ 6,581,305 total
Kovner Bruce
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-12-26$4.00/sh+31,197$124,698→ 6,563,105 total - Purchase
Ordinary Shares, $0.01 par value
2018-12-27$3.98/sh+18,200$72,434→ 6,581,305 total
Footnotes (1)
- [F1]Following the transactions reported herein, these shares represent (a) 6,244,501 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 336,804 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001576081
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 5:39 PM ET
- Size
- 10.7 KB